Actively Recruiting

Age: 18Years +
All Genders
NCT07023536

Effectiveness of a Cardiac Telerehabilitation Program in Chronic Heart Failure

Led by University of Salerno · Updated on 2026-03-11

205

Participants Needed

1

Research Sites

77 weeks

Total Duration

On this page

Sponsors

U

University of Salerno

Lead Sponsor

A

Azienda Ospedaliera OO.RR. S. Giovanni di Dio e Ruggi D'Aragona

Collaborating Sponsor

AI-Summary

What this Trial Is About

The goal of this observational study is to evaluate whether a home-based cardiac tele-rehabilitation program can improve functional capacity in adults (18 years and older) with chronic heart failure. The main questions it aims to answer are: Does tele-rehabilitation improve peak oxygen uptake (VO₂ max) compared to standard in-hospital rehabilitation? Does it improve cardiac function, exercise tolerance, biochemical markers, and quality of life? Are functional gains maintained at 24 weeks? Researchers will compare patients who opt for tele-rehabilitation using wearable devices and a remote monitoring platform with those undergoing standard in-person rehabilitation. Participants will follow an 8-week individualized training program and undergo assessments at baseline, 4, 8, 16, and 24 weeks.

CONDITIONS

Official Title

Effectiveness of a Cardiac Telerehabilitation Program in Chronic Heart Failure

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 2424 18 years
  • Diagnosis of chronic heart failure for at least 6 months with stable optimal medical therapy for at least 1 month
  • New York Heart Association (NYHA) functional class I, II, or III
  • Hospitalization or outpatient visit requiring intravenous therapy within the past 12 months
  • Ability to provide informed consent or have a legal representative
  • Digital literacy of the patient and/or caregiver
Not Eligible

You will not qualify if you...

  • Age under 18 years
  • Pregnancy
  • NYHA class IV heart failure
  • Severe renal insufficiency (eGFR <30 ml/min/1.73 m) or dialysis
  • Other serious illnesses limiting life expectancy (e.g., end-stage cancer, advanced pulmonary disease)

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Hospital University San Giovanni di Dio e Ruggi d'Aragona

Salerno, Italy

Actively Recruiting

Loading map...

Research Team

A

Alessia Bramanti, Electronic Engineering

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here